The Lonquex market is witnessing steady growth over the forecast period, supported by growing demand for long-acting supportive care drugs, rising biosimilar competition.
Read More
The Libtayo market is witnessing steady growth over the forecast period, supported by expansion of immunotherapy indications, rising investment in cancer biologics research.
Read More
The Libmeldy market is witnessing steady growth over the forecast period, supported by increasing approvals of gene therapies, rising investments in rare disease research.
Read More
The Leukine market is witnessing steady growth over the forecast period, supported by increasing demand for post-chemotherapy immune support, expansion of personalized oncology care.
Read More
The Leqvio market is witnessing steady growth over the forecast period, supported by increasing adoption of novel rna therapeutics, rising focus on cardiovascular risk reduction.
Read More
The Leqembi market is witnessing steady growth over the forecast period, supported by increasing investments in neurodegenerative disease research, rising adoption of early diagnostic tools.
Read More
The Lemtrada market is witnessing steady growth over the forecast period, supported by increasing demand for high-efficacy MS treatments, expansion of personalized immunotherapy approaches.
Read More
The Laviv market is witnessing steady growth over the forecast period, supported by increasing adoption of personalized regenerative aesthetics, rising geriatric population seeking skin rejuvenation.
Read More
The Lantus market is witnessing steady growth over the forecast period, supported by growing competition from biosimilar insulins, increasing focus on personalized insulin therapy.
Read More
The Lantidra market is witnessing steady growth over the forecast period, supported by expansion of curative diabetes treatment research, increasing adoption of cell therapies in endocrinology.
Read More